To help find the right cancer patients for the right treatments and clinical trials using big data and advanced analytics
Mark Rogers, MSc
Cofounder & CEO
15yrs+ in Emerging Biotech Business Development, Cell & Gene Therapy Research & Protein-Protein Interaction Screening. MSc in Molecular Biotechnology.
Previously Associate Director- Emerging Biotech at Merck KGaA & Cofounder of Curogenix
Pavel Kartasevs, MEng
Cofounder & CTO
10yrs experience in High-Performance Computing, Machine Learning, NLP, Bioinformatics & Software Engineering. MEng in Computer Engineering, MSc in Bioinformatics.
Previously Tech Lead at
UK Tech Start-up & Tutor in Bioinformatics at Cranfield University.
Anna O'Leary, BA
Cofounder & COO
10yrs experience in Business Operations. BA in Business & Finance.
Previously worked in management at Aramark, and in operations at RBS Global Banking & Markets (US) and at Aramark.
John Conway, MSc
Head of Machine Learning Research
20yrs in hands-on Data Analytics and Machine Learning research, and management of data science teams. MSc in Data Science. Previously, Director of Data Science at a FinTech startup.
David Kwon, MD, PhD, MBA
Advisor - Clinical Development & Digital Strategy
Currently, Executive Director of Clinical Development at Esperion. Previously, Global Medical Director at Novartis & Gilead.
Prof. Jody Haigh, PhD
Advisor - Oncology Pharmacology & Therapeutics
Professor of Pharmacology & Therapeutics, Haematological Oncology, CancerCare Manitoba. Previously worked at Monash University, Ghent University and the Research Institute of Molecular Pathology (IMP) in Vienna.
Advisor - Business Strategy & Technology
Chief Technology Officer at UC Berkeley. Berkeley Skydeck Advisor.
Niranjan Tulpule, BEng
Advisor & Investor - Knowledge graphs and software development
Engineering Director at Google
Sam Mercer, BSc
Consultant - Strategy & Business Development
Consultant, and Board Chairperson Vancouver Island Life Sciences. Previously, worked in clinical trial outsourcing at Novartis and Roche, and business development at Eupraxia.